DrugPipeline.net has announced the addition of “Cervical Cancer - Epidemiology Insights-2023 - United States” research report to their website DrugPipeline.net
Bangalore, India -- (SBWIRE) -- 11/23/2016 -- Cervical Cancer- Epidemiology Insights-2023- United States Report provides United States historical and forecasted epidemiological data for the incident cases of Cervical Cancer from 2013-2023. The report covers the incident population dissemination of cervical cancer for United States further providing the details on the local, regional, distant and unstaged Cervical Cancer.
Publisher estimates that the incidence rate for Cervical Cancer will increase at a Compound Annual Growth Rate of 0.01% in United States with total number of cases is expected to reach 13304 by 2023.
Cervical Cancer needs to be focused more and more because it adversely affects younger women. It is the fourth most common cause of death among women. Cervical Cancer occurs due to the uncontrolled growth of healthy cells in cervix and forms cervical lesions. It spreads to other tissues such as vagina and uterus. Cervical Cancer is caused by inheritance of defects or mutation in genes. Cervical cancer is also caused due to the infection by the Human Papilloma Virus (HPV) which can infect cells on the surface of the skin and those lining the genitals, anus, mouth and throat, but not the blood or internal organs such as the heart or lungs.
The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by Publisher team of industry experts.
Scope of the report
- The report has in depth analysis of patient population in the United States to improve the quality of life of women.
- It has covered the future perspective of Cervical Cancer for preventive purpose in the US.
- Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, and disease management.
- The Report covers the detailed global historical and forecasted epidemiological data United States from 2013-2023.
Spanning over 60 pages, 4 Tables and 6 Figures "Cervical Cancer - Epidemiology Insights-2023 - United States" report covers Cervical Cancer Disease Overview, Diagnosis of Cervical Cancer, Current treatment of Cervical Cancer, Epidemiology and Patient Population of Cervical Cancer, Key takeaways, Appendix.
For more information Visit at: http://www.drugpipeline.net/delveinsight/cervical-cancer-epidemiology-insights-2023-united-states
DrugPipeline.net is a market research reports distribution platform which hosts research reports from all leading global market research firms related to pharma industry. It also assist decision makers locate the right market research solution from a single place.